Proposed Tool to Compare and Assess the Applicability of Taste Assessment Techniques for Pharmaceuticals.

Acceptability Assessment Paediatric Pharmaceuticals Taste

Journal

Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R

Informations de publication

Date de publication:
05 2022
Historique:
received: 08 07 2021
revised: 02 09 2021
accepted: 02 09 2021
pubmed: 10 9 2021
medline: 21 4 2022
entrez: 9 9 2021
Statut: ppublish

Résumé

Palatability is amongst the most important determinants of whether or not a child will take a medicine. In order to increase concordance with treatment regimens it is often necessary to utilise a range of formulation techniques to improve the palatability of medicines. These can include selecting a different molecule or version of a molecule (such as a different polymorph or salt form), various taste masking techniques and/or the inclusion of flavours and sweeteners. In order to be able to understand the taste of the Active Pharmaceutical Ingredient (API) and to validate the formulation approach used, it is necessary to be able to use the most reliable taste evaluation method possible. Multiple in vivo and in vitro methods exist nowadays or are proposed in the literature but are often little understood by the pharmaceutical product development community. In particular, different methods may be more relevant at different stages of product development. The aim of this article is to propose a tool to guide the selection of the most appropriate method for the desired evaluation. A spreadsheet-based tool is proposed that is designed to allow the systematic assessment of the applicability of any taste assessment technique existing or new to the users proposed application. A series of criteria are defined that will allow the user to assess the analytical, usability and availability factors for the technique that is being considered. Such a systematic review will help the user to understand the benefits and risks of using each methodology for that application. The use of the tool is illustrated based on currently available data and literature. As new/existing methods are developed/improved, the outcomes of the tool may change.

Identifiants

pubmed: 34499899
pii: S0022-3549(21)00471-8
doi: 10.1016/j.xphs.2021.09.002
pii:
doi:

Substances chimiques

Flavoring Agents 0
Sweetening Agents 0

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1219-1223

Informations de copyright

Copyright © 2021 American Pharmacists Association. Published by Elsevier Inc. All rights reserved.

Auteurs

David Clapham (D)

Independent pharmaceutical consultant, Bishops Stortford, UK. Electronic address: david.clapham@ntlworld.com.

Joanne Bennett (J)

Pfizer R&D UK LTD, Sandwich, UK.

Anne Cram (A)

Pfizer R&D UK LTD, Sandwich, UK.

Angela Discihnger (A)

Pharmaceutical Research and Development, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland.

Sabine Inghelbrecht (S)

Janssen Research & Development, Johnson& Johnson, Beerse, Belgium.

Anne-Marie Pensé-Lhéritier (AM)

Ecole de Biologie Industrielle, Cergy, France.

Fabrice Ruiz (F)

ClinSearch, Malakoff, France.

Smita Salunke (S)

UCL School of Pharmacy, London, UK.

Julia Schiele (J)

Abbvie, Ludwigshafen, Germany.

Jessica Soto (J)

Novartis, Basel, Switzerland.

Jennifer Walsh (J)

Jenny Walsh Consulting, Nottingham, UK.

Catherine Tuleu (C)

UCL School of Pharmacy, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH